Author:
Pant P R,Shrivastava Uma,Simkhada Sabina,Sharma Swasti,Shrestha Chetna,Shrestha Usha,Lacoul Tumla
Abstract
In Luteal Phase Defect (LPD), endogenous progesterone is insufficient to maintain a functional secretory endometrium and also inhibit embryo growth and implant. In 1960, it was estimated that 20 million pregnancies were exposed to Dydrogesterone in utero. LOTUS I and LOTUS II two major multicenter Phase III studies were conducted on patients who were planning to undergo Fertilization (IVF) with or without Intracytoplasmic Sperm Injection (ICSI). The result of both studies shows that Dydrogesterone was non-inferior to micronized vaginal progesterone, which was the presence of fetal heartbeats at 12 weeks of gestation. Progesterone which can be administered either by oral preparation, vaginal administration along with optimal use of estrogen and Gonadotropin-Releasing Hormon (GnRH) agonist drugs is used in the treatment of LPD. Studies have suggested the use of Dydrogesterone in fresh IVF cycles and Luteal Phase Support (LPS) is continued till 10–12 weeks. However, it may be stopped at the time of β-hCG becoming positive or visualization of a fetal heartbeat.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference19 articles.
1. Salehpour S, Tamimi M, Saharkhiz N, Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.Iran J Reprod Med 2013;11(11):913-8
2. Mesen TB, Young SL, Progesterone and the Luteal Phase.Obstet Gynecol Clin North Am 2015;42(1):135-51
3. Tournaye H, Sukhikh GT, Kahler E, Griesinger G, A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.Hum Reprod 2017;32(5):1019-27
4. Griesinger G, Blockeel C, Sukhikh GT, Patki A, Dhorepatil B, Yang DZ, Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: A randomized clinical trial.Hum Reprod 2018;33(12):2212-21
5. Barbosa MW, Silva LR, Navarro PA, Ferriani RA, Nastri CO, Martins WP, Dydrogesterone vs progesterone for luteal-phase support: Aystematic review and meta-analysis of randomized controlled trials.Ultrasound Obstet Gynecol 2016;48(2):161-70